DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
This Quarter Return
-2.66%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$3.09B
AUM Growth
+$3.09B
(+16%)
Cap. Flow
+$741M
Cap. Flow
% of AUM
24.01%
Top 10 Holdings %
Top 10 Hldgs %
53.08%
Holding
78
New
16
Increased
25
Reduced
8
Closed
8
Top Buys
| 1 |
Protagonist Therapeutics
PTGX
|
$96.7M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$79.4M |
| 3 |
Tarsus Pharmaceuticals
TARS
|
$76.2M |
| 4 |
Akero Therapeutics
AKRO
|
$69.6M |
| 5 |
BridgeBio Pharma
BBIO
|
$68.5M |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$125M |
| 2 |
Harmony Biosciences
HRMY
|
$49.9M |
| 3 |
Neumora Therapeutics
NMRA
|
$42.4M |
| 4 |
Genmab
GMAB
|
$41.7M |
| 5 |
Guardant Health
GH
|
$41.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
4D Molecular Therapeutics
FDMT
$302M
| – | – |
-609,900
| Closed | -$3.4M |
|
|
77
Genmab
GMAB
$16.7B
| – | – |
-2,000,000
| Closed | -$41.7M |
|
|
78
Harmony Biosciences
HRMY
$2.16B
| – | – |
-1,450,000
| Closed | -$49.9M |
|